EcoR1 Capital LLC 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | EcoR1 Capital LLC | 1,060,010 3.000% | -1,473,625 (-58.16%) | Filing |
| 2021-01-04 4:42 pm Purchase | 2020-12-22 | 13G | ARS Pharmaceuticals, Inc. SPRY | EcoR1 Capital LLC | 2,533,635 7.300% | 2,533,635 (New Position) | Filing |